WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001032923) ANTISENSE INHIBITION OF PI3 KINASE P55 GAMMA EXPRESSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/032923    International Application No.:    PCT/US2000/029830
Publication Date: 10.05.2001 International Filing Date: 30.10.2000
Chapter 2 Demand Filed:    31.05.2001    
IPC:
A61K 38/00 (2006.01), C12N 15/11 (2006.01)
Applicants: ISIS PHARMACEUTICALS, INC. [US/US]; 2292 Faraday Avenue, Carlsbad, CA 92008 (US) (For All Designated States Except US).
BORCHERS, Alexander, H. [US/US]; (US) (For US Only).
WARD, Donna, T. [US/US]; (US) (For US Only).
COWSERT, Lex, M. [US/US]; (US) (For US Only)
Inventors: BORCHERS, Alexander, H.; (US).
WARD, Donna, T.; (US).
COWSERT, Lex, M.; (US)
Agent: LICATA, Jane, Massey; Law Offices of Jane Massey Licata, 66 E. Main Street, Marlton, NJ 08053 (US)
Priority Data:
09/433,694 03.11.1999 US
Title (EN) ANTISENSE INHIBITION OF PI3 KINASE P55 GAMMA EXPRESSION
(FR) INHIBITION ANTISENS DE L'EXPRESSION DE SOUS-UNITE P55 GAMMA DE PI3 KINASE
Abstract: front page image
(EN)Antisense compounds, compositions and methods are provided for inhibiting the expression of PI3 kinase p55 gamma. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PI3 kinase p55 gamma. Methods of using these compounds for inhibition of PI3 kinase p55 gamma expression and for treatment of diseases associated with expression of PI3 kinase p55 gamma are provided.
(FR)La présente invention concerne des composés antisens, des compositions et des méthodes destinés à inhiber l'expression de sous-unité p55 gamma de PI3 kinase. Les compositions comprennent des composés antisens, en particulier des nucléotides antisens ciblés sur des acides nucléiques codant pour cette sous-unité p55 gamma de PI3 kinase. L'invention concerne aussi des méthodes d'utilisation de ces composés destinés à inhiber l'expression de sous-unité p55 gamma de PI3 kinase et destinés au traitement de maladies associées à l'expression de sous-unité p55 gamma de PI3.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)